Literature DB >> 8708672

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease.

N Rösler, I Wichart, K A Jellinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8708672      PMCID： PMC1073823          DOI： 10.1136/jnnp.60.2.237-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer's disease--correlation with degree of cognitive impairment.

Authors:  C Hock; S Golombowski; W Naser; F Müller-Spahn
Journal:  Ann Neurol       Date:  1995-03       Impact factor: 10.422

3.  Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  C Vigo-Pelfrey; P Seubert; R Barbour; C Blomquist; M Lee; D Lee; F Coria; L Chang; B Miller; I Lieberburg
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910
  3 in total
  7 in total

1.  Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.

Authors:  N Rösler; I Wichart; K A Jellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

2.  Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

Authors:  N Rösler; I Wichart; K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

3.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Authors:  N Andreasen; E Vanmechelen; A Van de Voorde; P Davidsson; C Hesse; S Tarvonen; I Räihä; L Sourander; B Winblad; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

Review 4.  Biomarkers of Alzheimer's disease.

Authors:  Rebecca Craig-Schapiro; Anne M Fagan; David M Holtzman
Journal:  Neurobiol Dis       Date:  2008-10-28       Impact factor: 5.996

Review 5.  Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.

Authors:  Catherine Randall; Lisa Mosconi; Mony de Leon; Lidia Glodzik
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

Review 6.  CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Authors:  K Blennow; E Vanmechelen; H Hampel
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.682

7.  CSF tau and β-amyloid as biomarkers for mild cognitive impairment.

Authors:  Harald Hampel; Kaj Blennow
Journal:  Dialogues Clin Neurosci       Date:  2004-12       Impact factor: 5.986
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.